Akari Therapeutics Plc

Contributing Author

Recent Articles by Akari Therapeutics Plc

26 min	Akari Therapeutics Releases Virtual Investor "What This Means" Segment Highlighting its Recently Granted India Patent AKTX GlobeNewswire
Jun-18	Akari Therapeutics Bolsters Global IP Estate for its Novel Antibody Drug Conjugate (ADC) Immuno-Oncology Payload, PH1, with Recent Granting of Patent Protection Across India AKTX GlobeNewswire
May-29	Akari Therapeutics Releases "Meet the Team" Video Featuring Recently Appointed Mark F. Kubik, Head of Business Development - Oncology AKTX GlobeNewswire
May-22	Akari Therapeutics to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar AKTX GlobeNewswire
May-15	Akari Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update AKTX GlobeNewswire
May-01	Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development - Oncology AKTX GlobeNewswire